Trial Profile
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of VSV-Indiana HIV Gag Vaccine Given Intramuscularly in Healthy, HIV-1-Uninfected Adult Participants.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs HIV DNA vaccine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 04 Dec 2012 Results were reported in a Profectus BioSciences media release.
- 04 Dec 2012 Status changed from active, no longer recruiting to completed, as reported in a Profectus BioSciences media release.
- 01 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.